FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Wiernik

Research Profile

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Peter H Wiernik
Lenalidomide in lymphomas and chronic lymphocytic leukemia.
Ulrike Bacher; Michael R Bishop; Christopher N Bredeson; Mitchell S Cairo; Jeanette Carreras; Timothy S Fenske; Cesar O Freytes; Robert Peter Gale; John Gibson; Parameswaran Hari; David J Inwards; Luis M Isola; Evgeny Klyuchnikov; Ginna G Laport; Hillard M Lazarus; Jennifer Le-Rademacher; Richard T Maziarz; Harry C Schouten; Shimon Slavin; Sonali M Smith; Julie M Vose; Edmund K Waller; Peter H Wiernik; Philippe Armand
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?
Rangaswamy Chintapatla; Ramakrishna Battini; Peter H Wiernik
Chronic lymphocytic leukemia with essential thrombocythemia: asbestos exposure association?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Wiernik (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Peter H Wiernik
Lenalidomide in lymphomas and chronic lymphocytic leukemia.
Expert opinion on pharmacotherapy 2013;14(4):475-88.
2012: Ulrike Bacher; Michael R Bishop; Christopher N Bredeson; Mitchell S Cairo; Jeanette Carreras; Timothy S Fenske; Cesar O Freytes; Robert Peter Gale; John Gibson; Parameswaran Hari; David J Inwards; Luis M Isola; Evgeny Klyuchnikov; Ginna G Laport; Hillard M Lazarus; Jennifer Le-Rademacher; Richard T Maziarz; Harry C Schouten; Shimon Slavin; Sonali M Smith; Julie M Vose; Edmund K Waller; Peter H Wiernik; Philippe Armand
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?
Blood 2012;120(20):4256-62.
2012: Rangaswamy Chintapatla; Ramakrishna Battini; Peter H Wiernik
Chronic lymphocytic leukemia with essential thrombocythemia: asbestos exposure association?
Clinical advances in hematology & oncology : H&O 2012;10(11):752-5.
2012: Irene A Dy; Peter H Wiernik
Cocaine-levamisole thrombotic vasculopathy.
Seminars in thrombosis and hemostasis 2012;38(8):780-2.
2012: Peter H Wiernik; Frederick R Appelbaum; Peter A Cassileth; Gordon Dewald; Holly Gundacker; Haesook T Kim; Elisabeth Paietta; Marilyn L Slovak; Zhuoxin Sun; Martin S Tallman
Prognostic implications of additional chromosome abnormalities among patients with de novo acute promyelocytic leukemia with t(15;17).
Medical oncology (Northwood, London, England) 2012;29(3):2095-101.
2012: Jeremy B Samon; Peter H Wiernik; Alberto Ambesi-Impiobato; Mireia Castillo-Martin; Carlos Cordon-Cardo; Michael Hadler; John Jakubczak; Elisabeth Paietta; Janis Racevskis; Sophia Randolph; Jacob M Rowe; Adolfo Ferrando
Preclinical analysis of the γ-secretase inhibitor PF-03084014 in combination with glucocorticoids in T-cell acute lymphoblastic leukemia.
Molecular cancer therapeutics 2012;11(7):1565-75.
2012: Peter H Wiernik; Leo I Gordon; Thomas M Habermann; Howard S Hochster; Sandra J Horning; Hailun Li; Carl J Minniti; Tipu Nazeer; Gary R Shapiro; Edie Weller; Peter A Cassileth
Activity of topotecan 21-day infusion in patients with previously treated large cell lymphoma: long-term follow-up of an Eastern Cooperative Oncology Group study (E5493).
Leukemia & lymphoma 2012;53(6):1137-42.
2012: J Erika Haydu; Elisabeth Paietta; Janis Racevskis; Jacob M Rowe; Peter H Wiernik; Kim De Keersmaecker; Mary Kaye Duff; Adolfo Ferrando
An activating intragenic deletion in NOTCH1 in human T-ALL.
Blood 2012;119(22):5211-4.
2012: Giusy Della Gatta; Alberto Ambesi-Impiombato; Mukesh Bansal; Andrea Califano; Zachary W Carpenter; Kim De Keersmaecker; Jules P P Meijerink; Elisabeth Paietta; Teresa Palomero; Arianne Perez-Garcia; Janis Racevskis; Jacob M Rowe; Xavier Sole; Peter H Wiernik; Luyao Xu; Adolfo Ferrando
Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL.
Nature medicine 2012;18(3):436-40.
2011: Peter H Wiernik
Acute lymphoblastic leukemia of adulthood: progress or not?
Current treatment options in oncology 2011;12(4):303-11.
2011: Peter H Wiernik; Giridhar U Adiga
Single-agent rituximab in treatment-refractory or poor prognosis patients with chronic lymphocytic leukemia.
Current medical research and opinion 2011;27(10):1987-93.
2011: Shaji Kumar; Robert A Kyle; Hillard M Lazarus; Peigang Li; Michael Lill; Sagar Lonial; Angelo Maiolino; Navneet S Majhail; Kenneth R Meehan; Gustavo A Milone; Rajneesh Nath; David H Vesole; Ravi Vij; Dan T Vogl; Brendan Weiss; Peter H Wiernik; Baldeep Wirk; Mei-Jie Zhang; Natalie S Callander; Angela Dispenzieri; Cesar O Freytes; Robert Peter Gale; Mehdi Hamadani; Rammurti T Kamble; Amrita Krishnan; Parameswaran N Hari
Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis.
Blood 2011;118(7):1979-88.
2011: Peter H Wiernik; Mahadi A Baig; Sung H Lee; Janice P Dutcher; Elisabeth Paietta; Janis Racevskis
Survival more than 19 years after the diagnosis of accelerated phase of chronic myelocytic leukemia.
Clinical advances in hematology & oncology : H&O 2011;9(3):242-8.
2011: Peter H Wiernik; Dahlia Elkadi; Alvaro Luongo-Cespedes; Julio Battistoni; Silvina Rossi; Susana Caceres; Raul Platero; Norma Piriz; Alvaro Lamas
Detection of a new embryonic antigen (ESA-10) in the blood of patients with cancer: preliminary results in the United States.
Medical oncology (Northwood, London, England) 2011;28(1):67-70.
2010: Martin S Tallman; Haesook T Kim; Pau Montesinos; Frederick R Appelbaum; Javier de la Serna; John M Bennett; Guillermo Deben; Clara D Bloomfield; Jose Gonzalez; James H Feusner; Marcos Gonzalez; Robert E Gallagher; Jose D Gonzalez-San Miguel; Richard A Larson; Gustavo Milone; Elisabeth Paietta; Chelo Rayon; Jacob M Rowe; Concha Rivas; Charles Alan Schiffer; Edo Vellenga; Lois Shepherd; James L Slack; Peter H Wiernik; Cheryl L Willman; Miguel A Sanz
Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group.
Blood 2010;116(25):5650-9.
2010: Donna Reece; David H Vesole; Smriti Shrestha; Mei-Jie Zhang; Waleska S Pérez; Angela Dispenzieri; Gustavo A Milone; Muneer H Abidi; Harold Atkins; Asad Bashey; Christopher N Bredeson; Willem Bujan Boza; Cesar O Freytes; Robert Peter Gale; James L Gajewski; John Gibson; gregory alan hale; Shaji Kumar; Robert A Kyle; Hillard M Lazarus; Philip L McCarthy; Santiago Pavlovsky; Vivek Roy; Daniel J Weisdorf; Peter H Wiernik; Parameswaran N Hari
Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study.
Clinical lymphoma, myeloma & leukemia 2010;10(6):458-63.
2010: Peter H Wiernik; Janice P Dutcher; Xiapan Yao; Usha Venkatraj; Carla I Falkson; Jacob M Rowe; Peter A Cassileth
Phase II study of interleukin-4 in indolent B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E5Y92).
Journal of immunotherapy (Hagerstown, Md. : 1997) 2010;33(9):1006-9.
2010: Jacob M Rowe; Haesook T Kim; Peter A Cassileth; Hillard M Lazarus; Mark R Litzow; Peter H Wiernik; Martin S Tallman
Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology Group.
Cancer 2010;116(21):5012-21.
2010: Dahlia Elkadi; Peter H Wiernik; Sun Wing Tommy Richard Tong
Resolution of massive pleural effusion due to lymphoma with intrapleural interleukin-2.
American journal of hematology 2010;85(9):711-2.
2010: Janice P Dutcher; Evelyn L Morris; Bruce Gaynor; Elisabeth Paietta; Peter H Wiernik
A pilot study of carboplatin and mitoxantrone in blast crisis of chronic myeloid leukemia.
Medical oncology (Northwood, London, England) 2010;27(3):728-35.
2010: Peter H Wiernik
FLT3 inhibitors for the treatment of acute myeloid leukemia.
Clinical advances in hematology & oncology : H&O 2010;8(6):429-36, 444.
2010: Giridhar U Adiga; Khalid L Rehman; Peter H Wiernik
Permanent localized hair repigmentation following herpes zoster infection.
Archives of dermatology 2010;146(5):569-70.
2010: Karen K Ballen; Smriti Shrestha; Kathleen A Sobocinski; Mei-Jie Zhang; Asad Bashey; Brian J Bolwell; Francisco Cervantes; Steven M Devine; Robert Peter Gale; Vikas Gupta; Theresa E Hahn; William J Hogan; Nicolaus Kröger; Mark R Litzow; David I Marks; Richard T Maziarz; Philip L McCarthy; Gary Schiller; Harry C Schouten; Vivek Roy; Peter H Wiernik; Mary M Horowitz; Sergio Giralt; Mukta Arora
Outcome of transplantation for myelofibrosis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(3):358-67.
2010: Omer N Koç; Charles Redfern; Peter H Wiernik; Fred Rosenfelt; Jane N Winter; William D Carter; Dan P Gold; Morgan E Stewart; Richard G Ghalie; John F Bender
A phase 2 trial of immunotherapy with mitumprotimut-T (Id-KLH) and GM-CSF following rituximab in follicular B-cell lymphoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2010;33(2):178-84.
2009: Gregory C Kane; Michael R Grever; John I Kennedy; Mary Ann Kuzma; Alan R Saltzman; Peter H Wiernik; Nicole V Baptista
The anticipated physician shortage: meeting the nation's need for physician services.
The American journal of medicine 2009;122(12):1156-62.
2009: Thomas E Witzig; Peter H Wiernik; Timothy Moore; Craig Reeder; Craig Cole; Glen Justice; Henry Kaplan; Michael Voralia; Dennis Pietronigro; Kenichi Takeshita; Annette Ervin-Haynes; Jerome B Zeldis; Julie M Vose
Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(32):5404-9.
2009: Timothy S Fenske; Parameswaran Hari; Jeanette Carreras; Mei-Jie Zhang; Rammurti T Kamble; Brian J Bolwell; Mitchell S Cairo; Richard E Champlin; Yi-Bin Chen; Cesar O Freytes; Robert Peter Gale; gregory alan hale; Osman Ilhan; H Jean Khoury; John Lister; Dipnarine Maharaj; David I Marks; Reinhold Munker; Andrew L Pecora; Philip Rowlings; Thomas C Shea; Patrick J Stiff; Peter H Wiernik; Jane N Winter; J Douglas Rizzo; Koen van Besien; Hillard M Lazarus; Julie M Vose
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(11):1455-64.
2009: Peter H Wiernik; Fangxin Hong; John H Glick; John M Bennett
Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-up.
Leukemia & lymphoma 2009;50(10):1632-41.
2009: Sung Ho Lee; Elisabeth Paietta; Janis Racevskis; Peter H Wiernik
Complete resolution of leukemia cutis with sorafenib in an acute myeloid leukemia patient with FLT3-ITD mutation.
American journal of hematology 2009;84(10):701-2.
2009: Stephen J Salipante; Matthew E Mealiffe; Jeremy Wechsler; Maxwell M Krem; Yajuan Liu; Shinae Namkoong; Govind Bhagat; Tomas Kirchhoff; Kenneth Offit; Henry Lynch; Peter H Wiernik; Mikhail Roshal; Mary Lou McMaster; Margaret Tucker; Jonathan R Fromm; Lynn R Goldin; Marshall S Horwitz
Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(35):14920-5.
2009: Valeria Tosello; Marc R Mansour; Kelly Barnes; Maddalena Paganin; Maria Luisa Sulis; Sarah Jenkinson; Christopher G Allen; Rosemary E Gale; David C Linch; Teresa Palomero; Pedro J Real; Vundavalli Murty; Xiaopan Yao; Susan M Richards; Anthony Goldstone; Jacob Rowe; Giuseppe Basso; Peter H Wiernik; Elisabeth Paietta; Rob Pieters; Martin Horstmann; Jules P P Meijerink; Adolfo Ferrando
WT1 mutations in T-ALL.
Blood 2009;114(5):1038-45.
2009: Sung Ho Lee; Lool Abebe; Elisabeth Paietta; Avi Einzig; Peter H Wiernik
Reappearance of acute myeloid leukemia after almost 23 years of continuous complete remission.
American journal of hematology 2009;84(7):455-7.
2009: Adele K Fielding; Jacob M Rowe; Susan M Richards; Georgina Buck; Anthony V Moorman; I Jill Durrant; David I Marks; Andrew K McMillan; Mark R Litzow; Hillard M Lazarus; Letizia Foroni; Gordon Dewald; Ian M Franklin; Selina M Luger; Elisabeth Paietta; Peter H Wiernik; Martin S Tallman; Anthony H Goldstone
Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993.
Blood 2009;113(19):4489-96.
2009: Thomas M Habermann; Izidore S Lossos; Glen Justice; Julie M Vose; Peter H Wiernik; Kyle McBride; Kenton Wride; Annette Ervin-Haynes; Kenichi Takeshita; Dennis Pietronigro; Jerome B Zeldis; Joseph M Tuscano
Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma.
British journal of haematology 2009;145(3):344-9.
2009: Peter H Wiernik
Treatment of hematologic neoplasms with new immunomodulatory drugs (IMiDs).
Current treatment options in oncology 2009;10(1-2):1-15.
2008: Peter H Wiernik; Izidore S Lossos; Joseph M Tuscano; Glen Justice; Julie M Vose; Craig E Cole; Wendy Lam; Kyle McBride; Kenton Wride; Dennis Pietronigro; Kenichi Takeshita; Annette Ervin-Haynes; Jerome B Zeldis; Thomas M Habermann
Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4952-7.
2008: Shaji Kumar; Waleska S Pérez; Mei-Jie Zhang; Karen Ballen; Asad Bashey; L Bik To; Christopher N Bredeson; Mitchell S Cairo; Gerald J Elfenbein; Cesar O Freytes; Robert Peter Gale; John Gibson; Robert A Kyle; Martha Q Lacy; Hillard M Lazarus; Philip L McCarthy; Gustavo A Milone; Jan S Moreb; Santiago Pavlovsky; Donna Reece; David H Vesole; Peter H Wiernik; Parameswaran Hari
Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(10):1134-40.
2008: Sonali M Smith; Koen van Besien; Jeanette Carreras; Asad Bashey; Mitchell S Cairo; Cesar O Freytes; Robert Peter Gale; gregory alan hale; Brandon Hayes-Lattin; Leona A Holmberg; Armand Keating; Richard T Maziarz; Philip L McCarthy; Willis H Navarro; Santiago Pavlovsky; Harry C Schouten; Matthew Seftel; Peter H Wiernik; Julie M Vose; Hillard M Lazarus; Parameswaran Hari
Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(8):904-12.
2008: David I Marks; Waleska S Pérez; Wensheng He; Mei-Jie Zhang; Michael Bishop; Brian J Bolwell; Christopher N Bredeson; Edward A Copelan; Robert Peter Gale; Vikas Gupta; gregory alan hale; Luis M Isola; Ann Jakubowski; Armand Keating; Thomas R Klumpp; Hillard M Lazarus; Jane L Liesveld; Richard T Maziarz; Philip L McCarthy; Mitchell Sabloff; Gary Schiller; Jorge Sierra; Martin S Tallman; Edmond WALLER; Peter H Wiernik; Daniel J Weisdorf
Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission.
Blood 2008;112(2):426-34.
2008: Peter H Wiernik
Serum CA125 and PSA concentrations in patients with lymphoma.
Clinical advances in hematology & oncology : H&O 2008;6(7):527-31.
2008: Merat Esfahani; Peter H Wiernik; Mrilini Yeddu; Lool Abebe
Leukemic infiltration of the breast in acute lymphocytic leukemia (ALL).
Hematology (Amsterdam, Netherlands) 2008;13(2):101-6.
2008: Anthony H Goldstone; Susan M Richards; Hillard M Lazarus; Martin S Tallman; Georgina Buck; Adele K Fielding; Alan K Burnett; rajesh Chopra; Peter H Wiernik; Letizia Foroni; Elisabeth Paietta; Mark R Litzow; David I Marks; Jill Durrant; Andrew McMillan; Ian M Franklin; Selina M Luger; Niculae Ciobanu; Jacob M Rowe
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993).
Blood 2008;111(4):1827-33.
2008: Polly R Etkind; Alexandre Stewart; Peter H Wiernik
Mouse mammary tumor virus (MMTV)-like DNA sequences in the breast tumors of father, mother, and daughter.
Infectious agents and cancer 2008;3():2.
2008: Doru T Alexandrescu; Peter H Wiernik
Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia.
Medical oncology (Northwood, London, England) 2008;25(3):309-14.
2007: Anthony V Moorman; Christine J Harrison; Georgina A N Buck; Susan M Richards; Lorna M Secker-Walker; Mary Martineau; Gail H Vance; Athena M Cherry; Rodney R Higgins; Adele K Fielding; Letizia Foroni; Elisabeth Paietta; Martin S Tallman; Mark R Litzow; Peter H Wiernik; Jacob M Rowe; Anthony H Goldstone; Gordon W Dewald
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.
Blood 2007;109(8):3189-97.
2007: Dejan Juric; Norman J Lacayo; Meghan C Ramsey; Janis Racevskis; Peter H Wiernik; Jacob M Rowe; Anthony H Goldstone; Peter J O'Dwyer; Elisabeth Paietta; Branimir I Sikic
Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(11):1341-9.
2007: Doru T Alexandrescu; Janice P Dutcher; Peter H Wiernik
Capecitabine-induced pancolitis.
International journal of colorectal disease 2007;22(4):455.
2007: Constantin A Dasanu; Peter H Wiernik; Juan Vaillant; Doru T Alexandrescu
A complex pattern of melanonychia and onycholysis after treatment with pemetrexed for lung cancer.
Skinmed 2007;6(2):95-6.
2007: Sung Ho Lee; Peter H Wiernik
Adult T-cell leukemia/lymphoma presenting with bilateral hearing loss: a case report.
Medical oncology (Northwood, London, England) 2007;24(1):109-13.
2007: Doru T Alexandrescu; Peter H Wiernik
The influence of parental age and gender on anticipation in familial B-cell malignancies.
Medical oncology (Northwood, London, England) 2007;24(1):55-62.
2006: Kamran Darabi; Shailaja Kantamnei; Peter H Wiernik
Lenalidomide-induced warm autoimmune hemolytic anemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(35):e59.
2006: Thambi Dorai; Ihor S Sawczuk; Jaromir Pastorek; Peter H Wiernik; Janice P Dutcher
Role of carbonic anhydrases in the progression of renal cell carcinoma subtypes: proposal of a unified hypothesis.
Cancer investigation 2006;24(8):754-79.
2006: Doru T Alexandrescu; Juan Vaillant; Peter H Wiernik
Trastuzumab/docetaxel-induced nail dystrophy.
International journal of dermatology 2006;45(11):1334-6.
2006: Doru T Alexandrescu; Alexandria Garino; Kelly A Brown-Balem; Peter H Wiernik
Anticipation in families with Hodgkin's and non-Hodgkin's lymphoma in their pedigree.
Leukemia & lymphoma 2006;47(10):2115-27.
2006: Hillard M Lazarus; Susan M Richards; rajesh Chopra; Mark R Litzow; Alan K Burnett; Peter H Wiernik; Ian M Franklin; Martin S Tallman; Lucy Cook; Georgina Buck; I Jill Durrant; Jacob M Rowe; Anthony H Goldstone
Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993.
Blood 2006;108(2):465-72.
2006: Charles H Redfern; Troy H Guthrie; Alberto Bessudo; John J Densmore; Peter R Holman; Nalini Janakiraman; John P Leonard; Richard L Levy; Richard G Just; Mitchell R Smith; Fred P Rosenfelt; Peter H Wiernik; William D Carter; Daniel P Gold; Teresa J Melink; John C Gutheil; John F Bender
Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin's lymphoma resulting in durable clinical responses.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3107-12.
2006: Merat Esfahani; Evelyn L Morris; Janice P Dutcher; Peter H Wiernik
Blastic phase of chronic myelogenous leukemia.
Current treatment options in oncology 2006;7(3):189-99.
2006: Michael J. Hall; Loretta Li; Peter H Wiernik; Olufunmilayo I Olopade
BRCA2 mutation and the risk of hematologic malignancy.
Leukemia & lymphoma 2006;47(4):765-7.
2006: Doru T Alexandrescu; Sirisha Karri; Peter H Wiernik; Janice P Dutcher
Mitoxantrone, vinblastine and CCNU: long-term follow-up of patients treated for advanced and poor-prognosis Hodgkin's disease.
Leukemia & lymphoma 2006;47(4):641-56.
2006: Anuradha Kunthur; Peter H Wiernik; Janice P Dutcher
Renal parenchymal tumors and lymphoma in the same patient: case series and review of the literature.
American journal of hematology 2006;81(4):271-80.
2006: Peter H Wiernik; Polly R Etkind
Is mouse mammary tumor virus an etiologic agent of human breast cancer and lymphoma?
Southern medical journal 2006;99(2):108-10.
2006: Kevin P O'Boyle; Susan Coatsworth; Gillian Anthony; Mark Ramirez; Edward Greenwald; Ronald Kaleya; Jacob J Steinberg; Janice P Dutcher; Peter H Wiernik
Effects of desialylation of ovine submaxillary gland mucin (OSM) on humoral and cellular immune responses to Tn and sialylated Tn.
Cancer immunity 2006;6():5.
2005: Thambi Dorai; Ihor S Sawczuk; Jaromir Pastorek; Peter H Wiernik; Janice P Dutcher
The role of carbonic anhydrase IX overexpression in kidney cancer.
European journal of cancer (Oxford, England : 1990) 2005;41(18):2935-47.
2005: Jacob M Rowe; Georgina Buck; Alan K Burnett; rajesh Chopra; Peter H Wiernik; Susan M Richards; Hillard M Lazarus; Ian M Franklin; Mark R Litzow; Niculae Ciobanu; H Grant Prentice; Jill Durrant; Martin S Tallman; Anthony H Goldstone
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993.
Blood 2005;106(12):3760-7.
2005: Lydia Koulova; Yelena Novik; Geralyn Caliendo; Peter H Wiernik; Janice Dutcher
A phase 2 study of moderate dose interleukin-2 and granulocyte-macrophage colony-stimulating factor in patients with metastatic or unresectable renal cell carcinoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2005;28(6):576-81.
2005: K Scott Baker; Fausto R Loberiza; Hongmei Yu; Mitchell S Cairo; Brian J Bolwell; Willem A Bujan-Boza; Bruce M Camitta; Juan Jose Garcia; Winston G Ho; Jane L Liesveld; Dipnarine Maharaj; David I Marks; Kirk R Schultz; Peter H Wiernik; Axel R Zander; Mary M Horowitz; Armand Keating; Daniel J Weisdorf
Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7032-42.
2005: Peter H Wiernik; Polly R Etkind
The association between breast cancer and lymphoma.
Clinical advances in hematology & oncology : H&O 2005;3(9):695-6.
2005: Doru T Alexandrescu; Peter H Wiernik
Cutaneous manifestations of a catheter-related thrombus.
Archives of dermatology 2005;141(8):1049.
2005: Doru T Alexandrescu; Kevin P O'Boyle; A Feliz; A Fueg; Peter H Wiernik
Metastatic solid-pseudopapillary tumour of the pancreas: clinico-biological correlates and management.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2005;17(5):358-63.
2005: Doru T Alexandrescu; L Koulova; Peter H Wiernik
Unusual cutaneous involvement during plasma cell leukaemia phase in a multiple myeloma patient after treatment with thalidomide: a case report and review of the literature.
Clinical and experimental dermatology 2005;30(4):391-4.
2005: Doru T Alexandrescu; Peter H Wiernik
Multiple eruptive dermatofibromas occurring in a patient with chronic myelogenous leukemia.
Archives of dermatology 2005;141(3):397-8.
2005: Doru T Alexandrescu; Janice P Dutcher; John T Hughes; Jerry Kaplan; Peter H Wiernik
Strokes after intravenous gamma globulin: thrombotic phenomenon in patients with risk factors or just coincidence?
American journal of hematology 2005;78(3):216-20.
2005: Doru T Alexandrescu; Prasad Maddukuri; Peter H Wiernik; Janice P Dutcher
Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome associated with high-dose interleukin-2 for the treatment of metastatic melanoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2005;28(2):144-7.
2005: Doru T Alexandrescu; Niyati Bhagwati; Peter H Wiernik
Chemotherapy-induced scleroderma: a pleiomorphic syndrome.
Clinical and experimental dermatology 2005;30(2):141-5.
2005: Janice P Dutcher; Sandra Lee; Robert E Gallagher; Adel Z Makary; John D Hines; Harold Londer; John P Farnen; john bennett; Elisabeth Paietta; Jacob M Rowe; Olga Goloubeva; Peter H Wiernik
Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993).
Leukemia & lymphoma 2005;46(3):377-85.
2005: Henry T Lynch; Patrice Watson; stefano r tarantolo; Peter H Wiernik; Brigid Quinn-Laquer; Karin Isgur Bergsagel; Laetitia Huiart; O I Olopade; Hagay Sobol; Warren G Sanger; David Hogg; Dennis D Weisenburger
Phenotypic heterogeneity in multiple myeloma families.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(4):685-93.
2005: Doru T Alexandrescu; Juan Vaillant; Laura J Yahr; Pond Kelemen; Peter H Wiernik
Unusually large colon cancer cutaneous and subcutaneous metastases occurring in resection scars.
Dermatology online journal 2005;11(2):22.
2005: Peter H Wiernik
Plasma cell dyscrasias and leukemias.
Cancer chemotherapy and biological response modifiers 2005;22():343-89.
2005: Joseph A Sparano; Abdissa Negassa; Erick Lansigan; Robin Locke; Chamath R De Silva; Peter H Wiernik
Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-Hodgkin's lymphoma.
Medical oncology (Northwood, London, England) 2005;22(3):257-67.
2005: Doru T Alexandrescu; Janice P Dutcher; Peter H Wiernik
Metastatic melanoma: is biochemotherapy the future?
Medical oncology (Northwood, London, England) 2005;22(2):101-11.
2005: Doru T Alexandrescu; Niyati Bhagwati; B Fomberstein; D E Wolfe; A Feliz; Peter H Wiernik
Steroid-responsive inclusion body myositis associated with endometrial cancer.
Clinical and experimental rheumatology 2005;23(1):93-6.
2005: Lydia Koulova; Doru T Alexandrescu; Janice P Dutcher; Kevin P O'Boyle; Saji Eapen; Peter H Wiernik
Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
American journal of hematology 2005;78(1):49-54.
2004: Doru T Alexandrescu; Janice P Dutcher; Kevin P O'Boyle; Mehmet Albulak; Stanley Oiseth; Peter H Wiernik
Fatal intra-alveolar hemorrhage after rituximab in a patient with non-Hodgkin lymphoma.
Leukemia & lymphoma 2004;45(11):2321-5.
2004: Peter H Wiernik; Elisabeth Paietta; Olga Goloubeva; S J Lee; D Makower; John M Bennett; James L Wade Iii; C Ghosh; L S Kaminer; J Pizzolo; Martin S Tallman
Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998).
Leukemia 2004;18(10):1605-10.
2004: Merat Esfahani; Peter H Wiernik; Yelena Novik; Elisabeth Paietta; Janice P Dutcher
Idarubicin and standard-dose cytosine arabinoside in adults with recurrent and refractory acute lymphocytic leukemia.
Cancer 2004;101(6):1414-9.
2004: Polly R Etkind; Alexandre Stewart; Thambi Dorai; Daniel J Purcell; Peter H Wiernik
Clonal isolation of different strains of mouse mammary tumor virus-like DNA sequences from both the breast tumors and non-Hodgkin's lymphomas of individual patients diagnosed with both malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(17):5656-64.
2004: Elisabeth Paietta; Adolfo Ferrando; Donna Neuberg; John M Bennett; Janis Racevskis; Hillard Lazarus; Gordon Dewald; Jacob M Rowe; Peter H Wiernik; Martin S Tallman; A Thomas Look
Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemias.
Blood 2004;104(2):558-60.
2004: Thambi Dorai; Janice P Dutcher; David W Dempster; Peter H Wiernik
Therapeutic potential of curcumin in prostate cancer--V: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells.
The Prostate 2004;60(1):1-17.
2004: Peter H Wiernik
Second neoplasms in patients with chronic lymphocytic leukemia.
Current treatment options in oncology 2004;5(3):215-23.
2004: Elisabeth Paietta; Olga Goloubeva; Donna Neuberg; John M Bennett; Robert E Gallagher; Janis Racevskis; Gordon Dewald; Peter H Wiernik; Martin S Tallman
A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes.
Cytometry. Part B, Clinical cytometry 2004;59(1):1-9.
2004: Martin S Tallman; Haesook T Kim; Elisabeth Paietta; John M Bennett; Gordon Dewald; Peter A Cassileth; Peter H Wiernik; Jacob M Rowe
Acute monocytic leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of acute myeloid leukemia: a report from the Eastern Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(7):1276-86.
2004: Niyati S Bhagwati; Stanley J Oiseth; Lool S Abebe; Peter H Wiernik
Intravascular lymphoma associated with hemophagocytic syndrome: a rare but aggressive clinical entity.
Annals of hematology 2004;83(4):247-50.
2004: Dilip Unnikrishnan; Janice P Dutcher; Susan Garl; Nikita Varshneya; Richard Lucariello; Peter H Wiernik
Cardiac monitoring of patients receiving arsenic trioxide therapy.
British journal of haematology 2004;124(5):610-7.
2004: Adolfo Ferrando; Donna Neuberg; Richard K Dodge; Elisabeth Paietta; Richard A Larson; Peter H Wiernik; Jacob M Rowe; Michael A Caligiuri; Clara D Bloomfield; A Thomas Look
Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
Lancet 2004;363(9408):535-6.
2004: Julie M Vose; Douglas J Rizzo; Jing Tao-Wu; James O Armitage; Asad Bashey; Linda J Burns; Neal Christiansen; Cesar O Freytes; Robert Peter Gale; John Gibson; Sergio Giralt; Roger H Herzig; Charles F LeMaistre; Philip L McCarthy; Stephen D Nimer; Finn B Petersen; David P Schenkein; Peter H Wiernik; Joseph M Wiley; Fausto R Loberiza; Hillard M Lazarus; Koen van Biesen; Mary M Horowitz
Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(2):116-27.
2004: Jacob M Rowe; Donna Neuberg; William Friedenberg; John M Bennett; Elisabeth Paietta; Adel Z Makary; Jane L Liesveld; Camille N Abboud; Gordon Dewald; F Ann Hayes; Martin S Tallman; Peter H Wiernik
A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group.
Blood 2004;103(2):479-85.
2003: Donna Reece; Christopher N Bredeson; Waleska S Pérez; Sundar Jagannath; Mei-Jie Zhang; Karen K Ballen; Gerald J Elfenbein; Cesar O Freytes; Robert Peter Gale; Morie A Gertz; J Gibson; Sergio Giralt; Armand Keating; R A Kyle; D Maharaj; D Marcellus; Philip L McCarthy; Gustavo A Milone; Stephen D Nimer; Santiago Pavlovsky; L B To; Daniel J Weisdorf; Peter H Wiernik; J R Wingard; David H Vesole
Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of age.
Bone marrow transplantation 2003;32(12):1135-43.
2003: Peter H Wiernik; Peter A Cassileth; Traci Leong; H Clark Hoagland; John M Bennett; Elisabeth Paietta; Martin M Oken
A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
Leukemia & lymphoma 2003;44(9):1515-21.
2003: Huda S Salman; Alejandra Perez; Joseph A Sparano; Howard Ratech; Abdissa Negassa; Una Hopkins; Gina Villani; Joachim Fuks; Peter H Wiernik
Phase II trial of infusional cyclophosphamide, idarubicin, and etoposide in poor prognosis non-Hodgkin's lymphoma.
American journal of clinical oncology 2003;26(4):338-43.
2003: Elisabeth Paietta; Donna Neuberg; John M Bennett; Gordon Dewald; Jacob M Rowe; Peter A Cassileth; Larry D Cripe; Martin S Tallman; Peter H Wiernik
Low expression of the myeloid differentiation antigen CD65s, a feature of poorly differentiated AML in older adults: study of 711 patients enrolled in ECOG trials.
Leukemia 2003;17(8):1544-50.
2003: Arthur I Radin; Haesook T Kim; Barbara W Grant; john bennett; John M Kirkwood; James A Stewart; Richard G Hahn; Janice P Dutcher; Peter H Wiernik; Martin M Oken
Phase II study of alpha2 interferon in the treatment of the chronic myeloproliferative disorders (E5487): a trial of the Eastern Cooperative Oncology Group.
Cancer 2003;98(1):100-9.
2003: Giridhar U Adiga; Lool Abebe; Peter H Wiernik
Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review.
American journal of hematology 2003;72(4):267-73.
2003: Peter H Wiernik
Plasma cell myeloma and leukemia.
Cancer chemotherapy and biological response modifiers 2003;21():365-97.
2003: Kevin P O'Boyle; Ashwin Murigeppa; Dharamvir Jain; Leonard Dauber; Janice P Dutcher; Peter H Wiernik
Probable veno-occlusive disease after treatment with gemtuzumab ozogamicin in a patient with acute myeloid leukemia and a history of liver transplantation for familial hemochromatosis.
Medical oncology (Northwood, London, England) 2003;20(4):379-84.
2003: Ilya Blokh; Stanley J Oiseth; Joachim Fuks; Dharamuir Jain; Saji Eapen; Lydia Koulova; Doru T Alexandrescu; Yuan-Yi Li; Janice Dutcher; Peter H Wiernik
Metastatic choriocarcinoma in a middle-aged man presenting as a right thigh mass with venous thrombosis: a case report.
Medical oncology (Northwood, London, England) 2003;20(2):189-94.
2003: Muhammad R Abbasi; Joseph A Sparano; Catherine Sarta; Peter H Wiernik
Phase I trial of fludarabine and paclitaxel in non-Hodgkin's lymphoma.
Medical oncology (Northwood, London, England) 2003;20(1):53-8.
2002: Martin S Tallman; Janet W Andersen; Charles Alan Schiffer; Frederick R Appelbaum; James Feusner; William G Woods; Angela Ogden; Howard Weinstein; Lois Shepherd; Cheryl Willman; Clara D Bloomfield; Jacob M Rowe; Peter H Wiernik
All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.
Blood 2002;100(13):4298-302.
2002: Janice P Dutcher; Peter H Wiernik
Clinical impact of multidrug resistance in acute leukemia.
Leukemia research 2002;26(3):323-5.
2002: George Marcoullis; Lool Abebe; Dharamvir Jain; Richard Talusan; Niyati Bhagwati; Peter H Wiernik
Microangiopathic hemolysis refractory to plasmapheresis responding to docetaxel and cisplatin: a case report.
Medical oncology (Northwood, London, England) 2002;19(3):189-92.
2002: Daniel Weisdorf; Michael Bishop; Bernie Dharan; Brian J Bolwell; Jean Yves Cahn; Mitchell S Cairo; Sergio Giralt; John Klein; Hillard M Lazarus; Mark R Litzow; David Marks; Philip McCarthy; Carole B Miller; Gustavo A Milone; James Russell; Kirk R Schultz; Jorge Sierra; Peter H Wiernik; Armand Keating; Fausto R Loberiza; Craig Kollman; Mary Horowitz
Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(4):213-20.
2001: Peter H Wiernik
Treatment of human immunodeficiency virus-related lymphoma.
Seminars in hematology 2001;38(4 Suppl 10):27-31.
2001: Peter H Wiernik; M Ashwin; XP Hu; Elisabeth Paietta; K Brown
Anticipation in familial chronic lymphocytic leukaemia.
British journal of haematology 2001;113(2):407-14.
2001: Elisabeth Paietta; Donna Neuberg; S Richards; John M Bennett; L Han; Janis Racevskis; Gordon Dewald; Jacob M Rowe; Peter H Wiernik
Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity.
American journal of hematology 2001;66(3):189-96.
2001: Dilip Unnikrishnan; Janice P Dutcher; Nikita Varshneya; Richard Lucariello; M Api; Susan Garl; Peter H Wiernik; Salvatore A. Chiaramida
Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide.
Blood 2001;97(5):1514-6.
2001: Peter H Wiernik; T Leong; Martin M Oken; R S Neiman; T M Habermann; J M Bennett; S Schuster; J H Glick
Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481).
Leukemia & lymphoma 2001;40(3-4):357-63.
2000: Janice P Dutcher; Yelena Novik; Kevin P O'Boyle; G Marcoullis; C Secco; Peter H Wiernik
20th-century advances in drug therapy in oncology--Part. II.
Journal of clinical pharmacology 2000;40(10):1079-92.
2000: Martin S Tallman; Donna Neuberg; John M Bennett; C J Francois; Elisabeth Paietta; Peter H Wiernik; Gordon Dewald; Peter A Cassileth; Martin M Oken; Jacob M Rowe
Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience.
Blood 2000;96(7):2405-11.
2000: Janice P Dutcher; Yelena Novik; Kevin P O'Boyle; G Marcoullis; C Secco; Peter H Wiernik
20th-century advances in drug therapy in oncology--Part I.
Journal of clinical pharmacology 2000;40(9):1007-24.
2000: C Robles; K M Kim; Martin M Oken; John M Bennett; L Letendre; Peter H Wiernik; M J O'Connell; Peter A Cassileth
Low-dose cytarabine maintenance therapy vs observation after remission induction in advanced acute myeloid leukemia: an Eastern Cooperative Oncology Group Trial (E5483).
Leukemia 2000;14(8):1349-53.
2000: S Lee; Martin S Tallman; Martin M Oken; Peter A Cassileth; John M Bennett; Peter H Wiernik; Jacob M Rowe
Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia. Eastern Cooperative Oncology Group.
Leukemia 2000;14(8):1345-8.
2000: Sunil Badve; A Blumstein; Peter H Wiernik; Howard Ratech
Non-hodgkin malignant lymphoma with tissue neutrophilia: a report of 3 cases.
Archives of pathology & laboratory medicine 2000;124(5):735-8.
2000: Polly R Etkind; J Du; A Khan; J Pillitteri; Peter H Wiernik
Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(4):1273-8.
2000: Peter H Wiernik; S Q Wang; XP Hu; P Marino; Elisabeth Paietta
Age of onset evidence for anticipation in familial non-Hodgkin's lymphoma.
British journal of haematology 2000;108(1):72-9.
2000: Martin S Tallman; Janet W Andersen; Charles Alan Schiffer; Frederick R Appelbaum; James Feusner; Angela Ogden; Lois Shepherd; Jacob M Rowe; C François; Richard Larson; Peter H Wiernik
Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome.
Blood 2000;95(1):90-5.
1999: Della Makower; Ummekalsoom Malik; Yelena Novik; Peter H Wiernik
Therapeutic efficacy of theophylline in chronic lymphocytic leukemia.
Medical oncology (Northwood, London, England) 1999;16(1):69-71.
1999: X J Huang; Peter H Wiernik; Robert S Klein; Robert E Gallagher
Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases.
Medical oncology (Northwood, London, England) 1999;16(1):58-64.
1999: N A Jan; Avi Einzig; Mark Suhrland; Peter H Wiernik
Non-Hodgkin lymphoma in acquired immunodeficiency syndrome manifesting as bilateral hypopyon.
American journal of clinical oncology 1999;22(1):82-3.
1999: Peter H Wiernik
The war on healthcare professionals and healthcare delivery.
Cancer investigation 1999;17(2):164-9.
1998: Da-Cheng Zhou; Steven Hallam; S J Lee; Robert S Klein; Peter H Wiernik; Martin S Tallman; Robert E Gallagher
Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells.
Cancer research 1998;58(24):5770-6.
1998: Peter A Cassileth; David Harrington; Frederick R Appelbaum; Hillard M Lazarus; Jacob M Rowe; Elisabeth Paietta; Cheryl L Willman; D D Hurd; John M Bennett; K G Blume; David R Head; Peter H Wiernik
Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission.
The New England journal of medicine 1998;339(23):1649-56.
1998: H A Deshpande; XP Hu; P Marino; N A Jan; Peter H Wiernik
Anticipation in familial plasma cell dyscrasias.
British journal of haematology 1998;103(3):696-703.
1998: Peter H Wiernik; E S Greenwald; H Ball; J A Young; S Vogl
High-dose megestrol acetate in the treatment of patients with ovarian cancer who have undergone previous treatment: Eastern Cooperative Oncology Group Study PD884.
American journal of clinical oncology 1998;21(6):565-7.
1998: Elisabeth Paietta; Janis Racevskis; John M Bennett; Donna Neuberg; Peter A Cassileth; Jacob M Rowe; Peter H Wiernik
Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience.
Leukemia 1998;12(12):1881-5.
1998: Scott Wadler; Hilda Haynes; Alla Rozenblit; X Hu; Ronald Kaleya; Peter H Wiernik
Sequential phase II trials of fluorouracil and interferon beta ser with or without sargramostim in patients with advanced colorectal carcinoma.
The cancer journal from Scientific American 1998;4(5):331-7.
1998: Wei Ding; YP Li; L M Nobile; G Grills; I Carrera; Elisabeth Paietta; Martin S Tallman; Peter H Wiernik; Robert E Gallagher
Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy.
Blood 1998;92(4):1172-83.
1998: Peter H Wiernik; V Phillips; F J Camacho; Martin M Oken; M J O'Connell
Methylguazone, vindesine and cisplatin for the treatment of patients with relapsed or refractory malignant lymphoma: an Eastern Cooperative Oncology Group Study (PA482).
Leukemia & lymphoma 1998;30(5-6):619-24.
1998: Peter H Wiernik; D F Moore; J M Bennett; S E Vogl; J E Harris; S Luger; Martin M Oken; J H Glick
Phase II study of mitoguazone, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with diffuse histologic subtypes of non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Study (PE481).
Leukemia & lymphoma 1998;30(5-6):601-7.
1998: Yelena Novik; P Marino; Della Makower; Peter H Wiernik
Familial erythroleukemia: a distinct clinical and genetic type of familial leukemias.
Leukemia & lymphoma 1998;30(3-4):395-401.
1998: Peter H Wiernik; Janice P Dutcher; Avi Einzig; Joseph A Sparano; M Frank; W Friedenberg
Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease.
The cancer journal from Scientific American 1998;4(4):254-60.
1998: Joseph A Sparano; Peter H Wiernik; X Hu; Catherine Sarta; David H Henry; Howard Ratech
Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma.
Medical oncology (Northwood, London, England) 1998;15(1):50-7.
1998: Della Makower; P Marino; M Frank; Peter H Wiernik
Familial hairy cell leukemia.
Leukemia & lymphoma 1998;29(1-2):193-7.
1998: Markus Loeffler; Oana Brosteanu; Dirk Hasenclever; Michael Sextro; D Assouline; Alfred A Bartolucci; Peter A Cassileth; D Crowther; Volker Diehl; Richard I Fisher; R T Hoppe; P Jacobs; J L Pater; S Pavlovsky; E Thompson; Peter H Wiernik
Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):818-29.
1998: Elisabeth Paietta; J Andersen; J Yunis; Jacob M Rowe; Peter A Cassileth; Martin S Tallman; John M Bennett; Peter H Wiernik
Acute myeloid leukaemia expressing the leucocyte integrin CD11b-a new leukaemic syndrome with poor prognosis: result of an ECOG database analysis. Eastern Cooperative Oncology Group.
British journal of haematology 1998;100(2):265-72.
1997: John M Bennett; ML Young; J W Andersen; Peter A Cassileth; Martin S Tallman; Elisabeth Paietta; Peter H Wiernik; J M Rowe
Long-term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group experience.
Cancer 1997;80(11 Suppl):2205-9.
1997: Elisabeth Paietta; Janis Racevskis; Donna Neuberg; Jacob M Rowe; A H Goldstone; Peter H Wiernik
Expression of CD25 (interleukin-2 receptor alpha chain) in adult acute lymphoblastic leukemia predicts for the presence of BCR/ABL fusion transcripts: results of a preliminary laboratory analysis of ECOG/MRC Intergroup Study E2993. Eastern Cooperative Oncology Group/Medical Research Council.
Leukemia 1997;11(11):1887-90.
1997: Martin S Tallman; Janet W Andersen; Charles Alan Schiffer; Frederick R Appelbaum; James Feusner; Angela Ogden; Lois Shepherd; C Willman; Clara D Bloomfield; Jacob M Rowe; Peter H Wiernik
All-trans-retinoic acid in acute promyelocytic leukemia.
The New England journal of medicine 1997;337(15):1021-8.
1997: Ummekalsoom Malik; Janice P Dutcher; G Caliendo; Patrick LaSala; R Mitnick; Peter H Wiernik
Phase II trial of merbarone in patients with malignant brain tumors.
Medical oncology (Northwood, London, England) 1997;14(3-4):159-62.
1997: Robert E Gallagher; Cheryl L Willman; James L Slack; J W Andersen; YP Li; David S Viswanatha; Clara D Bloomfield; F R Appelbaum; Charles Alan Schiffer; Martin S Tallman; Peter H Wiernik
Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study.
Blood 1997;90(4):1656-63.
1997: YP Li; J Andersen; Arthur Zelent; S Rao; Elisabeth Paietta; Martin S Tallman; Peter H Wiernik; Robert E Gallagher
RAR alpha1/RAR alpha2-PML mRNA expression in acute promyelocytic leukemia cells: a molecular and laboratory-clinical correlative study.
Blood 1997;90(1):306-12.
1997: Janice P Dutcher; D Coletti; Elisabeth Paietta; Peter H Wiernik
A pilot study of alpha-interferon and plicamycin for accelerated phase of chronic myeloid leukemia.
Leukemia research 1997;21(5):375-80.
1997: M Y Ashigbi; U Venkatraj; V Agarwal; Jacqueline A Bello; Peter H Wiernik
Intracranial Hodgkin's disease in two patients with familial Hodgkin's disease.
Medical and pediatric oncology 1997;28(4):255-8.
1997: Yelena Novik; L Oleksowicz; Peter H Wiernik
Therapeutic effect of cyclosporine A in thrombocytopenia after myeloablative chemotherapy in acute myeloid leukaemia.
Medical oncology (Northwood, London, England) 1997;14(1):43-6.
1997: Kevin P O'Boyle; Y Wang; Edward L Schwartz; DL Regl; Avi Einzig; Janice P Dutcher; Peter H Wiernik; Susan B. Horwitz
Development of two radioimmunoassays to detect paclitaxel in sera and in cerebrospinal, ascitic, and pleural fluids.
Cancer 1997;79(5):1022-30.
1997: Joseph A Sparano; X Hu; Peter H Wiernik; Catherine Sarta; D M Reddy; Lawrence Hanau; David H Henry
Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.
Journal of the National Cancer Institute 1997;89(4):301-7.
1997: Peter H Wiernik
Leukemias and plasma cell myeloma.
Cancer chemotherapy and biological response modifiers 1997;17():390-407.
1997: Janice P Dutcher; U Venkatraj; Della Makower; Peter H Wiernik
Interleukin-4 is a pleotropic cytokine with effects on B-cell malignancies.
Leukemia research 1997;21(1):17-9.
1996: Peter H Wiernik; R De Bellis; P Muxi; J P Dutcher
Extramedullary acute promyelocytic leukemia.
Cancer 1996;78(12):2510-4.
1996: Ummekalsoom Malik; L Oleksowicz; Janice P Dutcher; Howard Ratech; Michael J Borowitz; Peter H Wiernik
Atypical clonal T-cell proliferation in infectious mononucleosis.
Medical oncology (Northwood, London, England) 1996;13(4):207-13.
1996: Peter H Wiernik
Lessons learned about treatment of the more common neoplasms from the study of acute leukemia.
The cancer journal from Scientific American 1996;2(6):356-9.
1996: Della Makower; U Venkatraj; Janice P Dutcher; Peter H Wiernik
Occurrence of myeloma in a chronic lymphocytic leukemia patients after response to differentiation therapy with interleukin-4.
Leukemia & lymphoma 1996;23(5-6):617-9.
1996: Joseph A Sparano; Peter H Wiernik; X Hu; Catherine Sarta; Edward L Schwartz; R Soeiro; David H Henry; B Mason; Howard Ratech; Janice P Dutcher
Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(11):3026-35.
1996: Scott Wadler; Hilda Haynes; Jonathan J Beitler; X Hu; S Fell; M Camacho; B Levine; Peter H Wiernik
Phase II clinical trial with 5-fluorouracil, recombinant interferon-alpha-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus.
Cancer 1996;78(1):30-4.
1996: Avi I Einzig; L M Schuchter; A Recio; S Coatsworth; R Rodriquez; Peter H Wiernik
Phase II trial of docetaxel (Taxotere) in patients with metastatic melanoma previously untreated with cytotoxic chemotherapy.
Medical oncology (Northwood, London, England) 1996;13(2):111-7.
1996: Peter H Wiernik
Interpreting data in AML.
Leukemia 1996;10 Suppl 1():S44-5.
1996: Scott Wadler; Hilda Haynes; Richard Schechner; Alla Rozenblit; Peter H Wiernik
Phase I trial of high-dose infusional hydroxyurea, high-dose infusional 5-fluorouracil and recombinant interferon-alpha-2a in patients with advanced malignancies.
Investigational new drugs 1996;13(4):315-20.
1996: Peter H Wiernik
Leukemias and myeloma.
Cancer chemotherapy and biological response modifiers 1996;16():347-75.
1996: C Secco; Peter H Wiernik; J M Bennett; Elisabeth Paietta
Acute leukemia with t(10;11)(p11-p15;q13-q23).
Cancer genetics and cytogenetics 1996;86(1):31-4.
1996: Elisabeth Paietta; J Andersen; Peter H Wiernik
A new approach to analyzing the utility of immunophenotyping for predicting clinical outcome in acute leukemia. Eastern Cooperative Oncology Group.
Leukemia 1996;10(1):1-4.
1995: Mark Hoffman; Peter H Wiernik; G J Kleiner
Acute promyelocytic leukemia and pregnancy. A case report.
Cancer 1995;76(11):2237-41.
1995: Janice P Dutcher; T Leong; A Z Makary; J Bennett; M Frontiera; H Miller; Peter H Wiernik
A phase II study of menogaril (7R-O-methylnogarol) in patients with relapsed/refractory acute myeloid leukemia: a study of the Eastern Cooperative Oncology Group.
Leukemia 1995;9(10):1638-42.
1995: Edward L Schwartz; S Hallam; Robert E Gallagher; Peter H Wiernik
Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia.
Biochemical pharmacology 1995;50(7):923-8.
1995: Robert E Gallagher; YP Li; S Rao; Elisabeth Paietta; J Andersen; PR Etkind; J M Bennett; Martin S Tallman; Peter H Wiernik
Characterization of acute promyelocytic leukemia cases with PML-RAR alpha break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid.
Blood 1995;86(4):1540-7.
1995: Elisabeth Paietta; J Andersen; Janis Racevskis; M Ashigbi; Peter A Cassileth; Peter H Wiernik
Modulation of multidrug resistance in de novo adult acute myeloid leukemia: variable efficacy of reverting agents in vitro. Eastern Cooperative Oncology Group.
Blood reviews 1995;9(1):47-52.
1995: Avi I Einzig; S Lipsitz; Peter H Wiernik; Al B Benson
Phase II trial of taxol in patients with adenocarcinoma of the upper gastrointestinal tract (UGIT). The Eastern Cooperative Oncology group (ECOG) results.
Investigational new drugs 1995;13(3):223-7.
1995: Scott Wadler; Hilda Haynes; Peter H Wiernik
Phase I trial of the somatostatin analog octreotide acetate in the treatment of fluoropyrimidine-induced diarrhea.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(1):222-6.
1995: A Khalil; N Ciobanu; Joseph A Sparano; Rasim Gucalp; Janice P Dutcher; Peter H Wiernik
Pilot study of high-dose mitoxantrone and busulfan plus autologous bone transplantation in patients with advanced malignancies.
Bone marrow transplantation 1995;15(1):93-7.
1994: G E Sagayadan; Peter H Wiernik; N Sun; G Ahearn; D Thompson; Steven Hallam; XP Hu; Janice P Dutcher; Robert E Gallagher
Effect of retinoic acid and interferon alpha on granulocyte-macrophage colony forming cells in chronic myeloid leukemia: increased inhibition by all-trans- and 13-cis-retinoic acids in advanced stage disease.
Leukemia research 1994;18(10):741-8.
1994: J P Dutcher; A Benchabbat; J G Jones; Peter H Wiernik
Unique dermatological complication of rhM-CSF treatment.
Leukemia & lymphoma 1994;15(3-4):347-9.
1994: Elisabeth Paietta; J Andersen; Robert E Gallagher; J Bennett; J Yunis; Peter A Cassileth; J Rowe; Peter H Wiernik
The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study.
Leukemia 1994;8(7):1108-12.
1994: Joseph A Sparano; Peter H Wiernik; M Strack; A Leaf; N H Becker; Catherine Sarta; D Carney; R Elkind; M Shah; E S Valentine
Infusional cyclophosphamide, doxorubicin and etoposide in HIV-related non-Hodgkin's lymphoma: a follow-up report of a highly active regimen.
Leukemia & lymphoma 1994;14(3-4):263-71.
1994: Elisabeth Paietta; J Andersen; Janis Racevskis; Robert E Gallagher; J Bennett; J Yunis; Peter A Cassileth; Peter H Wiernik
Significantly lower P-glycoprotein expression in acute promyelocytic leukemia than in other types of acute myeloid leukemia: immunological, molecular and functional analyses.
Leukemia 1994;8(6):968-73.
1994: L Welles; HD Dorfman; E S Valentine; Peter H Wiernik
Low grade malignant hemangioendothelioma of bone: a disease potentially curable with radiotherapy.
Medical and pediatric oncology 1994;23(2):144-8.
1994: D M Merer; Janice P Dutcher; A Mercando; R Brodman; Mark Suhrland; A Bhandari; D Zimmerman; M S Mitchell; Peter H Wiernik
Case report: clinical findings and successful resection of melanoma metastatic to the right atrium.
Cancer investigation 1994;12(4):409-13.
1994: Peter H Wiernik
Leukemias and myeloma.
Cancer chemotherapy and biological response modifiers 1994;15():391-412.
1994: Peter H Wiernik; N T Sklarin; J P Dutcher; Joseph A Sparano; E S Greenwald
Adjuvant radiotherapy for breast cancer as a risk factor for the development of lung cancer.
Medical oncology (Northwood, London, England) 1994;11(3-4):121-5.
1993: J P Dutcher; Peter H Wiernik
The role of recombinant interleukin-2 in therapy for hematologic malignancies.
Seminars in oncology 1993;20(6 Suppl 9):33-40.
1993: C Mazurek; Janice P Dutcher; Edward L Schwartz; S Garl; L Benson; Peter H Wiernik
Phase I clinical and pharmacokinetic study of menogaril (7-con-O-methylnogarol) in previously treated patients with acute leukemia.
Investigational new drugs 1993;11(4):313-22.
1993: Peter H Wiernik; Janice P Dutcher; Elisabeth Paietta; Rasim Gucalp; S Markus; V Weinberg; C Azar; S Garl; L Benson
Long-term follow-up of treatment and potential cure of adult acute lymphocytic leukemia with MOAD: a non-anthracycline containing regimen.
Leukemia 1993;7(8):1236-41.
1993: Joseph A Sparano; Scott Wadler; R B Diasio; R Zhang; Z Lu; Edward L Schwartz; Avi Einzig; Peter H Wiernik
Phase I trial of low-dose, prolonged continuous infusion fluorouracil plus interferon-alfa: evidence for enhanced fluorouracil toxicity without pharmacokinetic perturbation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(8):1609-17.
1993: Elisabeth Paietta; Janis Racevskis; J M Bennett; Peter H Wiernik
Differential expression of terminal transferase (TdT) in acute lymphocytic leukaemia expressing myeloid antigens and TdT positive acute myeloid leukaemia as compared to myeloid antigen negative acute lymphocytic leukaemia.
British journal of haematology 1993;84(3):416-22.
1993: Joseph A Sparano; Peter H Wiernik; A Leaf; Janice P Dutcher
Infusional cyclophosphamide, doxorubicin, and etoposide in relapsed and resistant non-Hodgkin's lymphoma: evidence for a schedule-dependent effect favoring infusional administration of chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(6):1071-9.
1993: P S Carlisle; Rasim Gucalp; Peter H Wiernik
Nosocomial infections in neutropenic cancer patients.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1993;14(6):320-4.
1993: Joseph A Sparano; Peter H Wiernik; M Strack; A Leaf; N Becker; E S Valentine
Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus- and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma: a highly active regimen.
Blood 1993;81(10):2810-5.
1993: Scott Wadler; S Fell; Hilda Haynes; H J Katz; Alla Rozenblit; Ronald Kaleya; Peter H Wiernik
Treatment of carcinoma of the esophagus with 5-fluorouracil and recombinant alfa-2a-interferon.
Cancer 1993;71(5):1726-30.
1993: C D Runowicz; Peter H Wiernik; Avi Einzig; Gary L Goldberg; Susan B. Horwitz
Taxol in ovarian cancer.
Cancer 1993;71(4 Suppl):1591-6.
1993: Rasim Gucalp; M Motyl; P Carlisle; J Dutcher; J Fuks; Peter H Wiernik
Clostridium cadaveris bacteremia in the immunocompromised host.
Medical and pediatric oncology 1993;21(1):70-2.
1992: N T Sklarin; Peter H Wiernik; W R Grove; L Benson; A Mittelman; J A Maroun; James A Stewart; F Robert; James Doroshow; P J Rosen
A phase II trial of CI-921 in advanced malignancies.
Investigational new drugs 1992;10(4):309-12.
1992: Avi Einzig; Peter H Wiernik; J Sasloff; C D Runowicz; Gary L Goldberg
Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(11):1748-53.
1992: Elisabeth Paietta; Brian Van Ness; J Bennett; Janis Racevskis; Rasim Gucalp; Peter A Cassileth; Peter H Wiernik
Lymphoid lineage-associated features in acute myeloid leukaemia: phenotypic and genotypic correlations.
British journal of haematology 1992;82(2):324-31.
1992: Elisabeth Paietta; Brian Van Ness; M M Le Beau; J Bennett; Peter A Cassileth; Peter H Wiernik
Translocation (2;9)(p12;p23) in a case of acute leukemia with t(4;11)(q21;q23). Lack of rearrangement of the kappa and interferon gene loci.
Cancer genetics and cytogenetics 1992;60(1):82-5.
1992: Craig Moskowitz; J P Dutcher; Peter H Wiernik
Association of thyroid disease with acute leukemia.
American journal of hematology 1992;39(2):102-7.
1992: Peter H Wiernik; P L Banks; D C Case; Z A Arlin; P O Periman; M B Todd; P S Ritch; R E Enck; A B Weitberg
Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia.
Blood 1992;79(2):313-9.
1992: Peter H Wiernik; B Yeap; S E Vogl; B H Kaplan; R L Comis; G Falkson; T E Davis; E Fazzini; B Cheuvart; J Horton
Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: a study of the Eastern Cooperative Oncology Group.
Cancer investigation 1992;10(1):1-9.
1992: Rasim Gucalp; P Ritch; Peter H Wiernik; P R Sarma; A Keller; Stephen Richman; K Tauer; J Neidhart; L E Mallette; R Siegel
Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(1):134-42.
1992: Peter H Wiernik; Janice P Dutcher
Clinical importance of anthracyclines in the treatment of acute myeloid leukemia.
Leukemia 1992;6 Suppl 1():67-9.
1991: Rasim Gucalp; N Ciobanu; Joseph A Sparano; M Motyl; P Carlisle; Peter H Wiernik
Disseminated aspergillosis after fungemia in a patient with extragonadal germ cell tumor undergoing autologous bone marrow transplantation.
Cancer 1991;68(8):1842-4.
1991: Elisabeth Paietta; Rasim Gucalp; Peter H Wiernik
Monosomy 7 in multilineage and acute lymphoblastic leukaemia.
British journal of haematology 1991;79(2):152-5.
1991: Peter H Wiernik; Janice P Dutcher; Elisabeth Paietta; W N Hittelman; R Vyas; M Strack; S Castaigne; L Degos; Robert E Gallagher
Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid.
Leukemia 1991;5(6):504-9.
1991: Rasim Gucalp; Elisabeth Paietta; V Weinberg; P Papenhausen; Janice P Dutcher; Peter H Wiernik
Terminal transferase expression in acute myeloid leukaemia: biology and prognosis.
British journal of haematology 1991;78(1):48-54.
1991: Joseph A Sparano; J B Beckwith; S Mitsudo; Peter H Wiernik
Complete remission in refractory anaplastic adult Wilms' tumor treated with cisplatin and etoposide.
Cancer 1991;67(4):956-9.
1991: Avi Einzig; H Hochster; Peter H Wiernik; D L Trump; Janice P Dutcher; E Garowski; J Sasloff; T J Smith
A phase II study of taxol in patients with malignant melanoma.
Investigational new drugs 1991;9(1):59-64.
1991: Elisabeth Paietta; Brian Van Ness; J M Bennett; C Pellone; Daniel D Billadeau; Peter A Cassileth; Peter H Wiernik
Unexpected immunoglobulin light chain gene rearrangements in myeloid antigen positive acute lymphoid leukemia.
Leukemia research 1991;15(2-3):149-55.
1991: D A Feinfeld; V D'Agati; Janice P Dutcher; S B Werfel; R I Lynn; Peter H Wiernik
Interstitial nephritis in a patient receiving adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells.
American journal of nephrology 1991;11(6):489-92.
1991: Avi Einzig; E Gorowski; J Sasloff; Peter H Wiernik
Phase II trial of taxol in patients with metastatic renal cell carcinoma.
Cancer investigation 1991;9(2):133-6.
1990: Janice P Dutcher; S L Marcus; Herbert B Tanowitz; M Wittner; J Z Fuks; Peter H Wiernik
Disseminated strongyloidiasis with central nervous system involvement diagnosed antemortem in a patient with acquired immunodeficiency syndrome and Burkitts lymphoma.
Cancer 1990;66(11):2417-20.
1990: C L Shalmi; Janice P Dutcher; D A Feinfeld; Kwang Chun; K R Saleemi; Leonard M Freeman; R I Lynn; Peter H Wiernik
Acute renal dysfunction during interleukin-2 treatment: suggestion of an intrinsic renal lesion.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(11):1839-46.
1990: Joseph A Sparano; Edward L Schwartz; K M Salva; M F Pizzillo; Scott Wadler; Peter H Wiernik
Phase II trial of etoposide, doxorubicin (Adriamycin), and cisplatin (EAP regimen) in advanced gastric cancer.
American journal of clinical oncology 1990;13(5):374-8.
1990: Janice P Dutcher; K M Salva; Peter H Wiernik
Successful treatment of hair cell leukemia with 2'-deoxycoformycin after failure of interferons alpha or beta.
American journal of clinical oncology 1990;13(4):290-3.
1990: Peter H Wiernik; M Rader; N H Becker; S F Morris
Inflammatory pseudotumor of spleen.
Cancer 1990;66(3):597-600.
1990: Scott Wadler; M Goldman; A Lyver; Peter H Wiernik
Phase I trial of 5-fluorouracil and recombinant alpha 2a-interferon in patients with advanced colorectal carcinoma.
Cancer research 1990;50(7):2056-9.
1990: Janice P Dutcher; C Riggs; J J Fox; G S Johnston; D Norris; Peter H Wiernik; Charles Alan Schiffer
Effect of histocompatibility factors on pulmonary retention of indium-111-labeled granulocytes.
American journal of hematology 1990;33(4):238-43.
1990: Elisabeth Paietta; Janis Racevskis; E Richard Stanley; M Andreeff; P Papenhausen; Peter H Wiernik
Expression of the macrophage growth factor, CSF-1 and its receptor c-fms by a Hodgkin's disease-derived cell line and its variants.
Cancer research 1990;50(7):2049-55.
1990: Peter H Wiernik; B Schwartz; Janice P Dutcher; N Turman; C Adinolfi
Successful treatment of hairy cell leukemia with beta-ser interferon.
American journal of hematology 1990;33(4):244-8.
1990: Joseph A Sparano; M Ramirez; Peter H Wiernik
Increasing recognition of corticosteroid-induced tumor lysis syndrome in non-Hodgkin's lymphoma.
Cancer 1990;65(5):1072-3.
1990: Scott Wadler; Peter H Wiernik
Clinical update on the role of fluorouracil and recombinant interferon alfa-2a in the treatment of colorectal carcinoma.
Seminars in oncology 1990;17(1 Suppl 1):16-21; discussion 38-41.
1989: Scott Wadler; Edward L Schwartz; M Goldman; A Lyver; M Rader; M Zimmerman; L Itri; V Weinberg; Peter H Wiernik
Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(12):1769-75.
1989: Scott Wadler; A Lyver; Peter H Wiernik
Clinical toxicities of the combination of 5-fluorouracil and recombinant interferon alfa-2a: an unusual toxicity profile.
Oncology nursing forum 1989;16(6 Suppl):12-5.
1989: Robert E Gallagher; F Said; I Pua; P R Papenhausen; Elisabeth Paietta; Peter H Wiernik
Expression of retinoic acid receptor-alpha mRNA in human leukemia cells with variable responsiveness to retinoic acid.
Leukemia 1989;3(11):789-95.
1989: Elisabeth Paietta; Rasim Gucalp; P Papenhausen; Janice P Dutcher; Peter H Wiernik
TdT+/nonlymphoid antigen+ acute leukemias: immunologic and karyotypic monitoring during therapy and at relapse suggests the transformation of a bipotential stem cell.
Leukemia 1989;3(7):485-91.
1989: E S Athan; Elisabeth Paietta; P R Papenhausen; Leonard H Augenlicht; Peter H Wiernik; Robert E Gallagher
Stability of multiple antigen receptor gene rearrangements and immunophenotype in Hodgkin's disease-derived cell line L428 and variant subline L428KSA.
Leukemia 1989;3(7):505-10.
1989: Janice P Dutcher; C E Riggs; J J Strauman; B Link; Peter H Wiernik
A phase I-II trial of 4'-deoxydoxorubicin (esorubicin) in refractory or relapsed acute leukemia.
Clinical pharmacology and therapeutics 1989;45(4):424-8.
1989: Elisabeth Paietta; M Andreeff; P Papenhausen; Rasim Gucalp; Peter H Wiernik
Distinct antigen expression related to DNA ploidy in a case of biphenotypic leukemia.
Leukemia 1989;3(1):76-8.
1989: Elisabeth Paietta; Richard J Stockert; A Morell; Janis Racevskis; Peter H Wiernik
A marker and putative pathoantigen of Hodgkin's cells.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;117():91-8.
1989: Peter H Wiernik
Current status of chemotherapy for Hodgkin's disease.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;117():132-41.
1989: Scott Wadler; Merrill J Egorin; E G Zuhowski; L Tortorello; K Salva; Carolyn D Runowicz; Peter H Wiernik
Phase I clinical and pharmacokinetic study of thiotepa administered intraperitoneally in patients with advanced malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(1):132-9.
1988: J Catanese; J P Dutcher; HD Dorfman; D F Andres; Peter H Wiernik
Mediastinal osteosarcoma with extension to lungs in a patient treated for Hodgkin's disease.
Cancer 1988;62(10):2252-7.
1988: K E Simon; Janice P Dutcher; C D Runowicz; Peter H Wiernik
Adenocarcinoma arising in vulvar breast tissue.
Cancer 1988;62(10):2234-8.
1988: Edward L Schwartz; Peter H Wiernik
Differentiation of leukemia cells by chemotherapeutic agents.
Journal of clinical pharmacology 1988;28(9):779-94.
1988: Elisabeth Paietta; P Papenhausen; Rasim Gucalp; Peter H Wiernik
Translocation t(12;19)(q13;q13.3). A new recurrent abnormality in acute nonlymphocytic leukemia with atypical erythropoiesis.
Cancer genetics and cytogenetics 1988;34(1):19-23.
1988: Janice P Dutcher; Peter H Wiernik; S Markus; V Weinberg; Charles Alan Schiffer; K V Harwood
Intensive maintenance therapy improves survival in adult acute nonlymphocytic leukemia: an eight-year follow-up.
Leukemia 1988;2(7):413-9.
1988: Scott Wadler; Avi Einzig; Janice P Dutcher; N Ciobanu; L Landau; Peter H Wiernik
Phase II trial of recombinant alpha-2b-interferon and low-dose cyclophosphamide in advanced melanoma and renal cell carcinoma.
American journal of clinical oncology 1988;11(1):55-9.
1988: Elisabeth Paietta; Robert E Gallagher; Peter H Wiernik; Richard J Stockert
A membrane-bound lectin responsive to monocytic maturation in the promyelocytic leukemia cell line HL-60.
Cancer research 1988;48(2):280-7.
1987: Elisabeth Paietta; P Papenhausen; Rasim Gucalp; J Reed; Peter H Wiernik
The 5q-- deletion: correlation of breakpoints with the immunophenotype of leukemic blast cells.
Leukemia 1987;1(12):822-4.
1987: Elisabeth Paietta; Richard J Stockert; T Calvelli; P Papenhausen; S V Seremetis; M Fotino; Peter H Wiernik; L Chang; F J Bollum
HL-T, a new cell line derived from HL-60 promyelocytic leukemia cell cultures expressing terminal transferase and secreting suppressor activity.
Blood 1987;70(4):1151-60.
1987: Peter H Wiernik; Edward L Schwartz; Avi Einzig; J J Strauman; richard lipton; Janice P Dutcher
Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(8):1232-9.
1987: J Z Fuks; S Wadler; Peter H Wiernik
Phase I and II agents in cancer therapy: two cisplatin analogues and high-dose cisplatin in hypertonic saline or with thiosulfate protection.
Journal of clinical pharmacology 1987;27(5):357-65.
1987: Peter H Wiernik; D Sciortino; Elisabeth Paietta; P Papenhausen; N Ciobanu; M Roberts
Plasma cell leukemia with an unusual karyotype and prolonged survival with oral alkylating agent therapy.
Journal of cancer research and clinical oncology 1987;113(6):576-8.
1987: Peter H Wiernik; D Sciortino; Elisabeth Paietta; P Papenhausen; N Ciobanu; M Roberts
Plasma cell leukemia with an unusual karyotype and prolonged survival following oral alkylating agent therapy.
Journal of cancer research and clinical oncology 1987;113(5):495-7.
1986: Elisabeth Paietta; P Papenhausen; N Ciobanu; J P Dutcher; Peter H Wiernik
Biphenotypic leukemia with unusual chromosomal translocation in a patient treated for melanoma.
Cancer genetics and cytogenetics 1986;21(4):355-60.
1985: Elisabeth Paietta; M Goldstein; P Papenhausen; N Ciobanu; Peter H Wiernik
Transformation of myeloma into Ph1-negative CML with plasma cell antigens.
American journal of hematology 1985;19(3):289-92.